Inhaled antimicrobial chemotherapy for respiratory tract infections: successes, challenges and the road ahead ☆
Clinical applications of pulmonary delivery of antibiotics ☆
Antimicrobial resistance, respiratory tract infections and role of biofilms in lung infections in cystic fibrosis patients ☆
Inhaled antimicrobial therapy – Barriers to effective treatment ☆
Preclinical safety and efficacy models for pulmonary drug delivery of antimicrobials with focus on in vitro models ☆
Pharmacokinetic and pharmacodynamic implications in inhalable antimicrobial therapy ☆
Inhaled anti-infective chemotherapy for respiratory tract infections: Successes, challenges and the road ahead ☆
Inhaled formulations and pulmonary drug delivery systems for respiratory infections ☆
Imaging regional lung function: A critical tool for developing inhaled antimicrobial therapies ☆
Comment on: Inhaled antimicrobial therapy—Barriers to effective treatment, by J.Weers, Adv. Drug Deliv. Rev. (2014), http://dx.doi.org/10.1016/j.addr.2014.08.013 ☆
Reply to the comment by de Boer and Hoppentocht on: Inhaled Antimicrobial therapy – Barriers to effective treatment, by J. Weers, Adv. Drug Deliv. Rev. (2015), http://dx.doi.org/10.1016/j.addr.2014.08.013 ☆
Comment on: Inhaled antimicrobial therapy—Barriers to effective treatment, by J. Weers, Inhaled antimicrobial therapy — Barriers to effective treatment, Adv. Drug Deliv. Rev. (2015), http://dx.doi.org/10.1016/j.addr.2014.08.013 ☆
Reply to the comment by Cipolla et al. on: Inhaled antimicrobial therapy—Barriers to effective treatment, by J. Weers, Adv. Drug Deliv. Rev. (2015), http://dx.doi.org/10.1016/j.addr.2014.08.013 ☆